CDK inhibitor PHA-848125, Purity ≥98%

Cat. No.: X24-05-ZQ728

CDK inhibitor PHA-848125, Purity ≥98%

Synonym: 802539-81-7; Milciclib; PHA848125; CDK inhibitor

  • CAS Number: 802539-81-7
  • Compound CID: 16718576
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
PHA-848125, soluble in DMSO and insoluble in ethanol and water, is an CDK kinase inhibitor that disrupts cell division processes. It targets CDK7/CyclinH, TrkA, CDK1/CyclinB, and CDK2/CyclinA.
Molecular Weight
460.6
Molecular Formula
C25H32N8O
Targets
CDK7/CyclinH: 150 nM; TrkA: 53 nM; CDK1/CyclinB: 398 nM; CDK2/CyclinA: 45 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 91 mg/mL (197.58 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
PHA-848125 can be used to study its dual inhibition of CDKs and TRKA/B/C, and its potential therapeutic effects in cancer.
Storage
Store at -20ºC.
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0